KENGREAL
Active substance: cangrelor
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CANGRELOR 50 mg/1
United StatesActive
Marketing holder: Chiesi USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CANGRELOR · 50 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-9550-7bd5-963f-d1ec5ffded37,01a12093-3d74-7aae-8e52-619f1c6c5b1b;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 10122-620
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 10122-620 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10122-620 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10122-620 · Verified 2026-10-09 · open in source